{"protocolSection":{"identificationModule":{"nctId":"NCT03890380","orgStudyIdInfo":{"id":"CLP-01"},"organization":{"fullName":"Magneto Thrombectomy Solutions","class":"INDUSTRY"},"briefTitle":"Safety and Performance Evaluation of the Magneto Wire","officialTitle":"Safety and Performance Evaluation of the Magneto Wire"},"statusModule":{"statusVerifiedDate":"2020-07","overallStatus":"TERMINATED","whyStopped":"Sponsor's decision","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2018-12-17","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2019-07-18","type":"ACTUAL"},"completionDateStruct":{"date":"2019-10-27","type":"ACTUAL"},"studyFirstSubmitDate":"2019-03-25","studyFirstSubmitQcDate":"2019-03-25","studyFirstPostDateStruct":{"date":"2019-03-26","type":"ACTUAL"},"lastUpdateSubmitDate":"2020-07-01","lastUpdatePostDateStruct":{"date":"2020-07-07","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Magneto Thrombectomy Solutions","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"A prospective, open label single arm feasibility study to evaluate the safety and performance of the Magneto Wire in patients diagnosed with acute ischemic stroke and planned for thrombectomy procedure."},"conditionsModule":{"conditions":["Ischemic Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":4,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Magneto Wire","type":"EXPERIMENTAL","description":"Patients treated with Magneto Wire","interventionNames":["Device: Magneto Wire"]}],"interventions":[{"type":"DEVICE","name":"Magneto Wire","description":"Patients will be treated with Magneto Wire","armGroupLabels":["Magneto Wire"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Safety Assessment","description":"Occurrence of Device-related Serious Adverse Events (SAEs)","timeFrame":"24 (±8) hours post procedure"}],"secondaryOutcomes":[{"measure":"Safety Assessment","description":"Occurrence of Device-related Serious Adverse Events (SAEs)","timeFrame":"90 (±10) days"},{"measure":"Revascularization","description":"Revascularization in the immediate post procedure angiogram, using modified Thrombolysis in Cerebrovascular Infarction (mTIC≥2b)","timeFrame":"immediate"},{"measure":"Distal Embolism","description":"Evidence of Infarction of a previously uninvolved vascular territory in the immediate post procedure angiogram","timeFrame":"immediate"},{"measure":"National Institutes of Health Stroke Scale (NIHSS)","description":"NIHSS scale is used to evaluate the severity of a stroke by assessing the stroke-related neurologic deficit. Scores range from 0-42, a higher score indicates a higher severity.","timeFrame":"24 (±8) hours post procedure"},{"measure":"Modified Rankin Scale","description":"Modified Rankin scale is used to evaluate the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. Scores range from 0-6 (0-no symptoms, 6- death)","timeFrame":"90 (±10) days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Acute ischemic stroke within defined timelines.\n* Age 18-85 years old\n* NIHSS ≥ 8\n* No significant pre-stroke functional disability (mRS ≤ 1)\n\nExclusion Criteria:\n\n* Life expectancy of less than 90 days\n* Neurological signs that are rapidly improving prior to or at time of treatment\n* NIHSS≥30 or state of coma\n* Ongoing seizure\n* Current use of cocaine or other vasoactive substance\n* Known bleeding diathesis\n* Known hemorrhagic or coagulation deficiency\n* Evidence of active systemic infection\n* Current use of oral anticoagulants INR \\> 3\n* Administration of heparin or Novel Oral Anticoagulants within 48 hours preceding the onset of stroke and have an abnormal aPTT at presentation\n* Platelet count \\< 50,000/mm3\n* Glucose \\<50 mg/dL (2.8 mmol, 2.6mM)\n* Uncontrolled hypertension (SBP\\>185 or DBP\\>110) refractory to pharmacological management\n* Known hypersensitivity or allergy to radiographic contrast agents\n* Pregnancy or lactating female\n* Subject already enrolled in a clinical study involving experimental medication or device\n* CT scan or MRI with evidence of acute intracranial hemorrhage, ASPECT score\\<6, mass effect and/or intracranial tumor.\n* Angiographic evidence of carotid dissection, or high grade stenosis that will prevent access to the clot, or cerebral vasculitis, or intracranial stenosis\n* Blood vessel with extreme tortuosity or other conditions preventing the access of the device.\n* Angiographic evidence of carotid dissection, complete cervical carotid occlusions or vasculitis.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Shally Sharon","affiliation":"Magneto Thrombectomy Solutions","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Rambam Health Care Campus","city":"Haifa","country":"Israel","geoPoint":{"lat":32.81841,"lon":34.9885}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000020521","term":"Stroke"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}